Evidence map›Paper›PMID 38410209›Full record

ArticleTranslational cancer research2024

A human serum albumin-indocyanine green complex offers improved tumor identification in fluorescence-guided surgery.

Yunlong Li, Chun Dai, Zhaolai Hua, Lin Xia, Yongbin Ding, Qiang Wang, Marie-Laure Matthey Gié, Michael Bouvet, Huiming Cai

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Yunlong Li *Department of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing University, Nanjing, China.
Chun Dai *Department of General Surgery, The People's Hospital of Yangzhong City, Yangzhong, China.
Zhaolai HuaDepartment of General Surgery, The People's Hospital of Yangzhong City, Yangzhong, China.
Lin XiaDepartment of General Surgery, The People's Hospital of Yangzhong City, Yangzhong, China.
Yongbin DingDepartment of General Surgery, Pukou Branch of Jiangsu People's Hospital, Nanjing, China.
Qiang WangSchool of Life Sciences, Jiangsu University, Zhenjiang, China.
Marie-Laure Matthey GiéDepartment of Thoracic and Endocrine Surgery, University Hospital of Geneva (HUG), Geneva, Switzerland.
Michael BouvetDepartment of Surgery, University of California, San Diego, CA, USA.
Huiming CaiNanjing Nuoyuan Medical Devices Co., Ltd., Nanjing, China.
People's Hospital of Yangzhong · CNClinica Luganese Moncucco · CHGovernment of Jiangsu Province · CNJiangsu University · CNNanjing University · CNUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Complete tumor removal is critical for achieving a good prognosis in patients but remains challenging for surgeons. Near-infrared fluorescence-guided surgery (NIRFGS) enables surgeons to accurately localize tumors in real time and facilitates accurate resection. Indocyanine green (ICG) has been approved by the U.S. Food and Drug Administration and the National Medical Products Administration for many years. Although the application of ICG has progressed for a variety of surgeries, there are inherent limitations to ICG, including poor water solubility and photostability, short blood half-life, and aggregation in blood, resulting in poor imaging performance. We found that mixing ICG with human serum albumin (HSA) preoperatively and then injecting it can improve the imaging performance. Methods: We prepared fluorescent probes by combining ICG with HSA and identified their optimal ratio via Results: Through Conclusions: This study suggests that ICG-HSA can achieve higher tumor-to-background contrast with shorter time and can provide an overall superior imaging performance compared to ICG alone, thus exhibiting considerable potential for clinical application.

Indexed as

human serum albumin (HSA)indocyanine green (ICG)Near-infrared fluorescence-guided surgery (NIRFGS)tumor imaging

Identifiers

PMID38410209
PMCPMC10894326
OpenAlexW4391377792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.